• Company
• Celltrion completes transfer of Takeda-acquired products
• by Ji Yong Jun Jan 27, 2022 05:43am

• Policy
• PVA guidelines are about to be revised
• by Lee, Hye-Kyung Jan 27, 2022 05:43am

• Policy
• The NHIS will begin research on improving the PVA system
• by Lee, Jeong-Hwan Jan 27, 2022 05:43am

• Company
• Sales of flu treatments have decreased significantly
• by Chon, Seung-Hyun Jan 27, 2022 05:42am

• Company
• KRPIA presidents will meet with Lee Joon-seok
• by Eo, Yun-Ho Jan 26, 2022 05:57am

• Company
• Outpatient prescriptions slow for MNCs...Viatris in the lead
• by Jan 26, 2022 05:57am

• Policy
• PVA price reduction needs to be improved
• by Lee, Jeong-Hwan Jan 26, 2022 05:57am

• Company
• SK Bioscience wins 3rd EU-GMP for its vaccine plant
• by Ji Yong Jun Jan 26, 2022 05:57am

• Policy
• The presidential candidate's pledge to expand NIP is fierce
• by Lee, Jeong-Hwan Jan 26, 2022 05:57am

• Company
• Montelukast sales 22%↓ in 2 years and adds impurity issue
• by Kim, Jin-Gu Jan 25, 2022 05:55am